Dr. Kunal Mehtani, MD

Dr. Mehtani practices at Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente.

Dr. Mehtani's NPI, 1699076182, was assigned on November 15, 2010. Dr. Mehtani graduated from American University of the Caribbean School of Medicine in 2007. Dr. Mehtani holds California license A114340.

Dr. Mehtani's primary practice is Kaiser Permanente South San Francisco Medical Center, at 1200 El Camino Real, South San Francisco, CA 94080 in San Mateo County. The practice phone is (650) 742-3200.

Dr. Mehtani's primary practice is Kaiser Permanente South San Francisco Medical Center in South San Francisco, California, part of Kaiser Permanente. Dr. Mehtani is also affiliated with San Francisco Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Mehtani to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehtani practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mehtani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mehtani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Mehtani is licensed in California.

CMS data shows 55 Medicare services from Dr. Mehtani across 1 procedure code in 2024, for 73 Medicare patients. Medicare paid $357 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Mehtani in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehtani's median patient age at 65, with 56% women.

In 2024, Dr. Mehtani wrote 1,890 Medicare Part D claims for 396 patients. 90% of them were for generic drugs. CMS names the drug for 1,778 of them, across 29 drugs with 11 or more claims each, at $143,971 in total drug cost. In 2023, CMS named 1,934 claims across 30 drugs.

Dr. Mehtani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Mehtani graduated from American University of the Caribbean School of Medicine in 2007. Dr. Mehtani is a member of ACC.

Dr. Mehtani is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.